Blood Cancer Discovery | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 6,

Issue 4

1 July 2025

About the Journal

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More About the Journal

Editors-in-Chief

Riccardo Dalla-Favera
Kenneth C. Anderson

View Full Editorial Board

Impact Factor

11.5

SUBMIT TO JOURNAL

Featured Articles

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

Nicole Thomas, et al.

Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation

Andy G.X. Zeng, et al.

Immune Escape of Acute Myeloid Leukemia after Transplantation

Nguyen Huong Jenny Giang Ho; Nana Talvard-Balland; Natalie Köhler; Robert Zeiser

Trending - Altmetric

$The article titled, Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium, has an Alt Metric Attention Score of 70.3. Click to see more of this article's metrics.$

Read the article titled, Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium

Last mentioned on Saturday July 12 2025

The article titled, An isoform-specific RUNX1C–BTG2 axis governs AML quiescence and chemoresistance., has an Alt Metric Attention Score of 10.1. Click to see more of this article's metrics.

Read the article titled, An isoform-specific RUNX1C–BTG2 axis governs AML quiescence and chemoresistance.

Last mentioned on Friday July 11 2025

The article titled, Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition, has an Alt Metric Attention Score of 27.1. Click to see more of this article's metrics.

Read the article titled, Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition

Last mentioned on Saturday July 12 2025

The article titled, Clinical Significance of TP53-Mutant Clonal Hematopoiesis Across Diseases, has an Alt Metric Attention Score of 8.6. Click to see more of this article's metrics.

Read the article titled, Clinical Significance of TP53-Mutant Clonal Hematopoiesis Across Diseases

Last mentioned on Saturday July 12 2025

The article titled, Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States., has an Alt Metric Attention Score of 1.5. Click to see more of this article's metrics.

Read the article titled, Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States.

Last mentioned on Thursday July 10 2025

Latest
Most Read
Most Cited

Microbiota shape metabolic and immune determinants of CAR-T therapy and correlate with outcomes in myeloma

Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium

An isoform-specific RUNX1C–BTG2 axis governs AML quiescence and chemoresistance.

Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States

About the Journal

Editors-in-Chief

Impact Factor

Featured Articles

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation

Immune Escape of Acute Myeloid Leukemia after Transplantation

Trending - Altmetric

AACR Journals

This Feature Is Available To Subscribers Only